person
Martin W.
- Country
- Germany
- Department
- Medical Oncology Department
Research Overview
assignment
64
Clinical Trials ·
- Dose-Escalation Study of Zongertinib in Patients with Advanced Non-Small Cell Lung Cancer and Solid Tumors with HER2 Aberrations
- Phase I Study of IMA401 TCER® in Patients with Solid Tumors: Monotherapy and Combination with Checkpoint Inhibitor
- Dose-Escalation Study of BI 764532 in Patients with DLL3-Positive Small Cell Lung Carcinoma and Neuroendocrine Neoplasms
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
263
Sites with multiple studies
Has run more than one trial at 263 of 463 partner sites.
Specializations
Lung Cancer Expertise
Specializes in various forms of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), with particular focus on targeted therapies for specific genetic mutations.
- EGFR-mutated NSCLC
- ROS1-positive NSCLC
- HER2-mutated lung cancers
- KRAS G12C mutations
Advanced Solid Tumors
Conducts research on novel therapeutic approaches for metastatic solid tumors across multiple cancer types, including innovative immunotherapy combinations.
- Melanoma
- Ovarian Cancer
- Breast Cancer
- Head and Neck Cancer
Innovative Therapies
Focuses on cutting-edge treatment approaches including cell-based therapies and targeted molecular treatments.
- CAR-T cell therapy
- Immunotherapy combinations
- Bispecific antibodies
- Personalized cancer treatments
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.